AlexandersonB., EvansD. A. P., SjoqvistF. (1969). Steady-state plasma levels of nortriptyline in twins; influence of genetic factors and drug therapy. British Medical Journal, 4, 764
2.
BrodieB. B., WeinerM., BurnsJ. J., SimsonG., YaleE. K. (1952). The physiological disposition of ethyl biscoumacetate (Tromexan) in man and a method for its estimation in biological material. Journal of Pharmacology and Experimental Therapeutics, 106, 453
3.
BrodieB. B., MaickelR. P. (1962). Comparative biochemistry of drug metabolism. Proceedings of 1st International Pharmacological Meeting. Metabolic Factors Controlling Duration of Drug Action, volume 6, p. 299. Edited by BrodieB. B. and ErdosE. G.London: Pergamon Press
4.
BrodieB. B. (1964). Distribution and fate of drugs; therapeutic implications. In Absorption and fate of drugs, p. 199. Edited by BinnsT. B.Baltimore: Williams and Wilkins
5.
ButlerT. C. (1958). Termination of drug action by elimination of unchanged drug. Federation Proceedings, 17, 1158
6.
ChristensenL. K., SkovstedL. (1969). Inhibition of drug metabolism by chloramphenicol. Lancet, 2, 1397
7.
ConneyA. H. (1967). Pharmacological implications of microsomal enzyme induction. Pharmacological Reviews, 19, 317
8.
DingellJ. V., HeimbergM. (1968). The effects of aliphatic halogenated hydrocarbons on hepatic drug metabolism. Biochemical Pharmacology, 17, 1269
9.
EvansD. A. P. (1965). Conjoint clinic on drugs and genes. Journal of Chronic Diseases, 18, 59
10.
FoutsJ. R. (1962). Physiological impairment of drug metabolism. Proceedings of 1st International Pharmacological Meeting. Metabolic Factors Controlling Duration of Drug Action, volume 6, p. 257. Edited by BrodieB.B. and ErdosE. G.London : Pergamon Press
11.
HammerW., MartensS., SjoqvistF. (1969). A comparative study of the metabolism of desmethylimipramine, nortriptyline, and oxyphenylbutazone in man. Clinical Pharmacology and Therapeutics, 10, 44
12.
KaltialaE. H. (1969). The effect of intestinal obstruction on liver microsomal enzymes. Acta Chirurgica Scandinavica, Supplement402, 9
13.
KolmodinB., AzarnoffD. L., SjoqvistF. (1969). Effect of environmental factors on drug metabolism: Decreased plasma half-life of antipyrine in workers exposed to chlorinated insecticides. Clinical Pharmacology and Therapeutics, 10, 638
14.
KuntzmanR., JacobsonM., LevinW., ConneyA. H. (1968). Stimulatory effect of N-phenylbarbita1 (Phetharbital) on cortisol hydroxylation in man. Biochemical Pharmacology, 17, 565
15.
Lancet (1969). Leading article. Analgesic abuse and tumours of the renal pelvis. Lancet, 2, 1233
16.
LeviA. J., SherlockS., WalkerD. (1968). Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy. Lancet, 1, 1275
17.
MacdonaldM. G., RobinsonD. S. (1968). Clinical observations of possible barbiturate interference with anticoagulation. Journal of the American Medical Association, 204, 95
18.
NelsonE. (1964). Rate of metabolism of tolbuamide in test subjects with liver disease or with impaired renal function. American Journal of the Medical Sciences, 248, 657
19.
ParkeD. V. (1968). The biochemistry of foreign compounds. London: Pergamon Press
20.
PrescottL. F. (1969). Pharmacokinetic drug interactions. Lancet, 2, 1239
21.
ShahidiN. T., HemaidanA. (1969). Acetophenetidin-induced methemoglobinemia and its relation to the excretion of diazotizable amines. Journal of Laboratory and Clinical Medicine, 74, 581
22.
SjoqvistF., HammerW., IdestromC. M., LindM., TuckD., AsbergM. (1967). Plasma level of monomethylated tricyclic antidepressants and side-effects in man. Excerpta Medica International Congress Series No. 145. Proceedings of the European Society for the Study of Drug Toxicity, Volume 9, Toxicity and Side-effects of Psychotropic Drugs, p. 246
23.
WeissC. F., GlazkoA. J., WestonJ. K. (1960). Chloramphenicol in the newborn infant. A physiologic explanation of its toxicity when given in excessive doses. New England Journal of Medicine, 262, 787
24.
WelchR. M., HarrisonY. E., ConneyA. H., PoppersP. J., FinsterM. (1968). Cigarette smoking: Stimulatory effect on metabolism of 3, 4-Benzpyrene by enzymes in human placenta. Science, 160, 541